7Vote!
In the Pipeline (Free subscription) | 11/06/2009
So what are we up to now, Day Three of Greater Merck? The merger with Schering-Plough went through earlier this week, and you won't get any more numbers by searching the stock tickers for SGP. I find that weird, since I started my career there in the late 1980s/early 1990s. But while I was there, it seemed like there were mergers and rumors of mergers every few weeks. That's no doubt a hindsight-enhanced...
+Vote!
Capital Observer (Free subscription) | 11/06/2009
Charles Biderman, founder of Trim Tabs, has done extensive studies on liquidity. When a company is bought out in a cash takeover, investors holding the shares are likely to take the cash they receive and buy other stock. His models show that half of the cash infusion is realized the week the deal is announced as arbs buy stock from shareholders. The other half is realized the week of closing. In the...
3Vote!
Japan Times (Free subscription) | 11/05/2009
GENEVA (Kyodo) The International Federation of Pharmaceutical Manufacturers & Associations said Wednesday that Eisai Co. President Haruo Naito has assumed the presidency, becoming the first Japanese to head the Geneva-based industry body. His predecessor, Fred Hassan, chairman and chief executive officer of Schering-Plough Corp., stepped down as his firm's merger with Merck & Co. was completed...
3Vote!
Capital Observer (Free subscription) | 11/05/2009
By my rough calculation, there will be a $1.5 billion buy program at the end of the day today relating to the S&P 500 changes of the Merck/Schering Plough merger.
4Vote!
Fiercebiotech (Free subscription) | 11/05/2009
Merck CEO Richard Clark ( photo ) went to some pains yesterday to make it clear that the merger with Schering-Plough in no way diminishes the pharma giant's appetite for biotech deals. If anything, he says, the bigger company has only grown more hungry. Over the past six years Merck has averaged 50 deals a year, Clark tells the AP . And it has $8 billion in the bank for the planned deal-making spree....
5Vote!
Wisconsin Technology Network (Free subscription) | 11/05/2009
Merck CEO `Actively Looking' for Biotech Deals...A day after closing Merck's $41 billion takeover of Schering-Plough, Merck CEO Dick Clark showed that his appetite for deal-making hasn't been sated. Clark told us today that the newly combined company is “actively looking” for biotechs to buy or partner with. Read More
5Vote!
Philadelphia Inquirer (Free subscription) | 11/05/2009
A day after completing the $41 billion takeover of Schering-Plough Corp., Merck & Co. Inc. chief executive officer Richard Clark reaffirmed yesterday that Montgomery County was an important base for the pharmaceutical giant and repeated that job cuts remained unlikely there.
5Vote!
Seattle Times (Free subscription) | 11/04/2009
A day after drugmaker Merck & Co. completed its $41.1 billion purchase of rival Schering-Plough Corp., Fitch Ratings Service on Wednesday cut its ratings on Merck and upgraded Schering-Plough.
5Vote!
Seattle Post-Intelligencer (Free subscription) | 11/04/2009
NEW YORK -- A day after drugmaker Merck & Co. completed its $41.1 billion purchase of rival Schering-Plough Corp., Fitch Ratings Service on Wednesday cut its ratings on Merck and upgraded Schering-Plough.
5Vote!
Fool.com (Free subscription) | 11/04/2009
Gone but not forgotten, in semi-free verse.
4Vote!
Business Wire (Free subscription) | 11/04/2009
CHICAGO--(BUSINESS WIRE)--As a result of the completed merger between Merck & Co., Inc. (Merck) and Schering-Plough Corp. (Schering-Plough) yesterday, Fitch Ratings has downgraded Merck's Issuer Default Rating (IDR) to 'A+' from 'AA-' and upgraded Schering-Plough's IDR to 'A+' from 'BBB+'. Simultaneously, Fitch downgraded Merck's senior unsecured debt and bank loan ratings to 'A+' from 'AA-' and...
5Vote!
The Philadelphia Business Journal (Free subscription) | 11/04/2009
Merck said Wednesday, a day after its $41.1 billion acquisition of Schering-Plough was completed, that its global Human Health Division and Merck Research Laboratories will be based at Merck’s existing facilities in Upper Gwynedd, Pa. (MRK)
3Vote!
Capital Observer (Free subscription) | 11/04/2009
My pharma positions are on fire today. MRK is up over 5%. LLY and PFE are up 2%. This is likely the result of the Schering Plough money being put to work in other pharma stocks.
4Vote!
WSJ.com (Free subscription) | 11/04/2009
Merck said it expects savings of $3.5 billion after the completion Tuesday of its acquisition of fellow drug maker Schering-Plough.
4Vote!
MarketIntelligenceCenter.com (Free subscription) | 11/04/2009
Merck (NYSE: MRK) opened at $31.33. So far today, the stock has hit a low of $31.25 and a high of $31.65. MRK is now trading at $31.42, up $0.74 (2.41%). Over the last 52 weeks the stock has ranged from a low of $20.05 to a high of $34.18. MRK completed its planned merger with Schering Plough overnight, and is now the world's second-largest drugmaker in terms of revenue. The company said upon completion...
5Vote!
aarkstore | 09/04/2009
omprehensive Forecasts AND Detailed Budget Benchmarks "Oncology Roadmap," explores the fiercely competitive oncology market in a way that no other available forecast can match. Our experienced analysts have reviewed thousands of historical and forecasted data points to provide the most comprehensive oncology market outlook ever. At the same time, brand budget benchmarks reveal spending in key areas...
2Vote!
aarkstore | 08/13/2009
The animal health market is growing, albeit at a slower rate, in the recessionary economic phase. Two factors are working in favor of the industry – pet owners’ love for their companion animals and the economic reasons for the treatment of livestock or farm animals. The “livestock” segment, a high-volume market that represents around 57% of the international animal health market is guided mostly by...
2Vote!
pickpennystocks | 08/07/2009
TransDigm Group has purchased Acme Aerospace Business from Actuant Corporation for $40 million. TransDigm supplies aircraft companies with components and the addition of Acme Aerospace will accentuate TransDigm Group’s products. WPPS, a leading financial newsletter, is pleased to alert investors of stocks on the move. Sign...
Videos